Research draft

cerebrospinal fluid

vr.tr.cerebrospinal-fluid · PHY.LIV

Enable an AI agent to identify cerebrospinal fluid, assess its compartment-specific state and evidential reliability, and determine which observations, analyses or clinically authorized interventions its record supports.

Thing Registry Physical world and living systems

Research draft, second pass

A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.

Researched by: Codex + Grok

Purpose and description

Cerebrospinal fluid (CSF) is the clear, colourless extracellular fluid produced mainly by the choroid plexuses that fills the brain's ventricular system and the subarachnoid space around brain and spinal cord, providing mechanical cushioning, chemical homeostasis, and a route for waste clearance.

It can be Associate a CSF observation or specimen with its organism, anatomical compartment and collection event.; Compare serial CSF measurements after checking site, method, handling and reference-context compatibility.; Track tubes, aliquots, remaining volume and assay-specific preservation requirements.; Assemble evidence for CSF identity or suspected leakage and identify unresolved confounders.; Flag results that meet a laboratory's documented escalation criteria for clinician review.; Record clinician-authorized sampling, drainage or intrathecal exposure and link subsequent CSF observations to that event..

Distinguishing features

Check documented origin in a ventricular or subarachnoid CSF space; fluid recovered from neural tissue alone does not establish CSF identity.

For suspected nasal or ear leakage, assess CSF-specific laboratory evidence rather than identifying clear discharge by appearance; beta-2 transferrin supports identification but has exceptions, including ocular-fluid contamination. [ARUP Consult](https://arupconsult.com/content/csf-leak-beta-2-transferrin)

Distinguish blood-contaminated CSF from a blood specimen using collection provenance and analytical evidence; red coloration alone does not resolve identity.

Distinguish authentic CSF from artificial CSF, saline or irrigation-fluid mixtures through organism provenance and preparation or exposure records.

Scope

+ Identity and anatomical provenance of a CSF compartment, collection or specimen

+ CSF pressure, movement, volume estimates and containment

+ Physical appearance, cellular content and chemical composition

+ Microbiological, immunological and other requested analytical findings

+ Sampling effects, contamination, preservation and fitness for a particular assay

+ Evidence supporting monitoring, further testing or referral for an authorized intervention

- Brain, spinal cord, meninges and choroid plexus as anatomical structures

- Blood, plasma and neural interstitial fluid as independently modeled fluids

- Neurological diseases and patient-level diagnostic or treatment decisions

- Lumbar puncture, surgery and intrathecal administration as procedures

- Shunts, drains, catheters and analytical instruments as devices

- Artificial CSF formulations as manufactured laboratory materials

Characteristics

Organism and physiological context: Organism identifier, species, age or developmental stage, linked clinical context Defines whose fluid is represented and which reference evidence may apply.
Anatomical origin and present location: Ventricular, cranial subarachnoid, spinal subarachnoid, escaped, collected; precise site or unknown Separates fluid origin from its current location and prevents unsupported comparisons between compartments.
CSF identity assessment: Supported, suspected, indeterminate, contradicted; evidence and assessor Prevents suspected leakage or an ambiguous specimen from becoming confirmed CSF by labeling alone.
Pressure observation: cm H2O or mmHg, with site, method, posture, time and opening/closing/continuous designation Makes a pressure value interpretable within its measurement conditions.
Fluid amount: mL, explicitly classified as estimated compartment volume, collected volume, aliquot volume or drained volume Prevents specimen or drainage quantities from being mistaken for total CSF volume.
Flow observation: Method-specific velocity or flow units, anatomical site, direction and observation interval Distinguishes local motion measurements from inferred whole-system circulation.
Appearance: Color, clarity, visible blood or clot; observation before or after processing Preserves an initial observation without treating appearance as a diagnosis.
Cellular profile: Red and nucleated cells per µL; differential percentages or absolute counts Supports assessment of cellular abnormalities and possible blood admixture.
Chemical profile: Analyte-specific concentrations, including protein and glucose, with laboratory units and reference intervals Records the chemical evidence used in CSF analysis. [MedlinePlus](https://medlineplus.gov/lab-tests/cerebrospinal-fluid-csf-analysis/)
Paired blood specimen: Linked serum or plasma specimen, collection time and matched analytes Supports analyses that require comparison with systemic concentrations.
Targeted analytical result: Named target, method, quantitative or qualitative result, detection limits and laboratory interpretation Keeps each microbiological, immune or molecular result tied to what was actually tested.
Assay-specific specimen fitness: Acceptable, conditionally acceptable, rejected, unassessed; assay and reason Makes usability depend on the requested analysis and actual handling history.

Where this came from

wikidata · CC0 1.0

Source repository Registry entry point

Drafted structure

Bundle to layer to finding to question, as the second pass will find it: 6 bundles · 12 layers · 12 findings · 25 questions.

CSF identity and compartments Establish what fluid is represented, where it originated and how confidently it is identified.

CSF in a physiological space, an escaped collection and a laboratory tube require different identity evidence.

Anatomical provenance

Connect the fluid to its organism and source compartment.

Origin and representation

Record whether the subject is an in-body fluid compartment, escaped fluid or a collected specimen.

Which organism and anatomical CSF space does this record represent? provenance
Is its present location also its origin, or was it collected, diverted or leaked elsewhere? boundary

Fluid identification

Separate supported CSF identity from visual resemblance or collection labels.

Identity evidence and mixtures

Record identifying evidence alongside possible blood, secretion, irrigation-fluid or artificial-CSF admixture.

What anatomical, collection or laboratory evidence supports calling this fluid CSF? definition
Which alternative fluids or mixtures remain plausible, and what evidence would distinguish them? boundary

CSF pressure, flow and containment Represent mechanical observations of CSF and evidence concerning its retention or escape.

A chemical profile cannot establish CSF pressure, circulation or containment.

Pressure and amount

Keep pressure measurements and fluid quantities attached to their acquisition conditions.

Conditioned mechanical measurements

Distinguish directly measured pressure and collected quantities from estimated physiological quantities.

Where, when, in what posture and by which method was pressure measured? measurement
Does a reported volume describe a compartment estimate, specimen, aliquot or drainage interval? measurement

Circulation and escape

Attach flow and leakage assessments to a specific anatomical route.

Flow and containment evidence

Record observations supporting altered passage, diversion or escape without equating a single measurement with a complete mechanism.

Which route was examined, and does the evidence describe local pulsatile motion, net transport or drainage? measurement
What evidence supports or leaves unresolved an obstruction, leak or abnormal diversion? boundary

CSF composition and biological signals Describe the measured physical, cellular, chemical and targeted biological state of CSF.

An agent needs separate observations and interpretive limits rather than a single normal-or-abnormal label.

Appearance and cells

Capture macroscopic observations and cellular measurements.

Appearance and cellular profile

Preserve color, clarity, cell counts and differential with processing context.

What were the color and clarity, and were they assessed before or after centrifugation? measurement
What red-cell count, nucleated-cell count and differential were measured in each identified tube? measurement

Chemistry and paired comparisons

Record chemical concentrations and the blood comparisons needed by the selected analysis.

Analytes and comparators

Keep measured CSF analytes separate from calculated ratios and interpretive conclusions.

Which concentrations were measured, using what units, methods and applicable reference intervals? measurement
Which paired serum or plasma results and collection times support any reported ratio or index? provenance

Targeted biological assays

Represent requested pathogen, immune, cytological or molecular investigations.

Target and detection boundaries

Identify what each assay investigated and what its result can establish.

Which organism, antibody, cell population or molecular marker was sought, and what result was reported? measurement
Which detection limits, treatment exposures or specimen limitations constrain interpretation of a negative or positive result? boundary

CSF collection and specimen integrity Trace how CSF became a specimen and whether subsequent handling preserves its intended evidential use.

Collection and processing can make a specimen differ from the fluid state an agent is trying to assess.

Collection and admixture

Preserve collection route, tube sequence and possible introduced material.

Sampling effects

Record collection circumstances relevant to blood admixture, dilution and site-dependent comparison.

Was CSF obtained by lumbar puncture, ventricular access, a drain or collection of suspected leakage, and at what time? provenance
What tube sequence, procedural observations or recent flushing support possible blood contamination or dilution? provenance
What evidence remains necessary to distinguish collection-related blood from blood already present in CSF? boundary

Preservation and aliquots

Connect specimen transformations and available volume to assay requirements.

Assay-specific usability

Assess each intended analysis against documented transport, storage and processing conditions.

What elapsed times, temperatures, containers, processing steps and freeze-thaw events apply to this aliquot? provenance
Does the receiving laboratory accept this aliquot and remaining volume for the requested CSF assay? action

CSF interpretation and permitted actions Turn qualified CSF observations into bounded comparisons, review requests and records of authorized action.

An agent must distinguish a fluid finding from a patient diagnosis and know what evidence or authority an action requires.

Context and change

Assess reference applicability and comparability of repeated observations.

Interpretable state and trend

Express which measurements support a state assessment and which uncertainties prevent one.

Which reference evidence applies to this species, age, collection site and analytical method? boundary
Are serial differences interpretable after accounting for site, timing, treatment and specimen handling? measurement

Review and intervention links

Connect CSF evidence to explicit review criteria and separately authorized clinical procedures.

Action readiness

Record whether evidence supports further analysis, escalation or tracking of a clinician-authorized intervention.

Which documented result or uncertainty requires additional analysis or clinician review under the applicable protocol? action
Which clinical authorization and procedure record govern any proposed CSF sampling, drainage or intrathecal administration? action
Which subsequent CSF observations are required to evaluate the recorded intervention? action

Evidence and external alignment What the world already says about this thing, gathered so the model can be checked against it.

A model that cannot be lined up against existing standards, identifiers and practice cannot be adopted by anyone who already uses them.

Reported evidence

Findings from the breadth pass, kept separate from the structural claims.

Kinds and varieties

Reported by the breadth pass; each item needs checking against its source before it becomes normative.

ventricular CSF (lateral, third, and fourth ventricles)
cisternal CSF (cisterna magna and other basal cisterns)
lumbar CSF (lumbosacral subarachnoid space; the usual diagnostic sample)
blood-stained or traumatic-tap CSF versus truly xanthochromic CSF
hydrocephalic / high-pressure CSF versus low-pressure CSF
infectious (bacterial, viral, fungal, mycobacterial) CSF
neoplastic / malignant CSF (leptomeningeal carcinomatosis or lymphoma)
iatrogenic or shunt-related CSF (external ventricular drain, lumbar drain, VP shunt fluid)

Which of these kinds and varieties hold for the sense of cerebrospinal fluid this model covers, and on what evidence? provenance

Sources

Physiology, Cerebral Spinal Fluid - Production by choroid plexus, circulation through ventricles and subarachnoid space, volume and daily turnover, composition versus plasma, and clinical roles of CSF analysis.

What the second pass must settle

Which species, developmental stages, sampling sites and assay methods need distinct reference profiles before this model can support state judgments?
What evidence standards should resolve CSF identity in mixed leakage specimens, including beta-2 transferrin confounders and indeterminate results?
Which approaches to interpreting blood-contaminated CSF are sufficiently validated for each intended use, and when must interpretation remain unresolved?
How should the model represent uncertain production, clearance and interstitial-exchange mechanisms without presenting a single circulation theory as settled?
Which laboratory-specific preservation limits, critical-result criteria and clinical authorization requirements must be linked before operational use?

Draft as JSON